Hyundai Pharmaceutical registered insect bites treatment 'Bumooly S' as OTC drug approved by the U.S. FDA

Hyundai Pharmaceutical registered insect bites treatment 'Bumooly S' as OTC drug approved by the U.S. FDA.

According to Hyundai Pharmaceutical, they completed U.S. FDA register of 'Bumooly S' and two OTC drugs including 'Moolpas-F Hyundai', and got credit for efficacy and safety.

Anti-inflammatory analgesic 'Moolpas-F Hyundai' has already entered the market in overseas such as Hong Kong, and ...